There are 2867 resources available
375P - The co-mutations and genetic features of BRAF-mutated gene mutations in a large Chinese MSS colorectal cancer cohort
Presenter: Size Chen
Session: Poster session 08
376P - Impact of anti-EGFR therapies on HER2-positive metastatic colorectal cancer (HER2+ mCRC): A systematic literature review and meta-analysis of clinical outcomes
Presenter: Tanios Bekaii-Saab
Session: Poster session 08
377P - Intraindividual tumor heterogeneity of mismatch repair status in metastatic colorectal cancer
Presenter: Gang Liu
Session: Poster session 08
378P - Liquid biopsy detects early molecular response and predicts benefit to first-line chemotherapy plus cetuximab in metastatic colorectal cancer: PLATFORM-B study
Presenter: JOANA Vidal Barrull
Session: Poster session 08
379P - Whole exome sequencing of plasma circulating tumor DNA identifies dynamic mutational changes to guide targeted therapies in colon cancer patients
Presenter: Jorge Martín-Arana
Session: Poster session 08
380P - Tumour naïve circulating tumour DNA (ctDNA) analysis in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial
Presenter: Daphne Day
Session: Poster session 08
381P - A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgery
Presenter: Sae-Won Han
Session: Poster session 08
382P - Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study
Presenter: Manuel Valladares
Session: Poster session 08
384P - Concordance of genomic alterations in tumour tissue and ctDNA in patients with colorectal cancer referred for early phase trials
Presenter: Neal Ramchander
Session: Poster session 08